Works matching AU McCrimmon, Rory J.

Results: 123
    1
    2
    3

    Associations of clinical, psychological, and sociodemographic characteristics and ecological momentary assessment completion in the 10‐week Hypo‐METRICS study: Hypoglycaemia MEasurements ThResholds and ImpaCtS.

    Published in:
    Diabetic Medicine, 2024, v. 41, n. 8, p. 1, doi. 10.1111/dme.15345
    By:
    • Zaremba, Natalie;
    • Martine‐Edith, Gilberte;
    • Divilly, Patrick;
    • Søholm, Uffe;
    • Broadley, Melanie;
    • Ali, Namam;
    • Abbink, Evertine J.;
    • de Galan, Bastiaan;
    • Cigler, Monika;
    • Mader, Julia K.;
    • Brosen, Julie;
    • Pedersen‐Bjergaard, Ulrik;
    • Vaag, Allan;
    • Evans, Mark;
    • Renard, Eric;
    • McCrimmon, Rory J.;
    • Heller, Simon;
    • Speight, Jane;
    • Pouwer, Frans;
    • Amiel, Stephanie A.
    Publication type:
    Article
    4
    5
    6

    Hypo‐METRICS: Hypoglycaemia—MEasurement, ThResholds and ImpaCtS—A multi‐country clinical study to define the optimal threshold and duration of sensor‐detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol

    Published in:
    Diabetic Medicine, 2022, v. 39, n. 9, p. 1, doi. 10.1111/dme.14892
    By:
    • Divilly, Patrick;
    • Zaremba, Natalie;
    • Mahmoudi, Zeinab;
    • Søholm, Uffe;
    • Pollard, Daniel J.;
    • Broadley, Melanie;
    • Abbink, Evertine J.;
    • de Galan, Bastiaan;
    • Pedersen‐Bjergaard, Ulrik;
    • Renard, Eric;
    • Evans, Mark;
    • Speight, Jane;
    • Brennan, Alan;
    • McCrimmon, Rory J.;
    • Müllenborn, Matthias;
    • Heller, Simon;
    • Seibold, Alexander;
    • Mader, Julia K.;
    • Amiel, Stephanie A.;
    • Pouwer, Frans
    Publication type:
    Article
    7

    Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.

    Published in:
    Diabetologia, 2023, v. 66, n. 7, p. 1340, doi. 10.1007/s00125-023-05907-6
    By:
    • McNeilly, Alison D.;
    • Gallagher, Jennifer R.;
    • Evans, Mark L.;
    • de Galan, Bastiaan E.;
    • Pedersen-Bjergaard, Ulrik;
    • Thorens, Bernard;
    • Dinkova-Kostova, Albena T.;
    • Huang, Jeffrey-T.;
    • Ashford, Michael L. J.;
    • McCrimmon, Rory J.
    Publication type:
    Article
    8
    9
    10

    Flash monitor initiation is associated with improvements in HbA<sub>1c</sub> levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.

    Published in:
    Diabetologia, 2022, v. 65, n. 1, p. 159, doi. 10.1007/s00125-021-05578-1
    By:
    • Jeyam, Anita;
    • Gibb, Fraser W.;
    • McKnight, John A.;
    • O'Reilly, Joseph E.;
    • Caparrotta, Thomas M.;
    • Höhn, Andreas;
    • McGurnaghan, Stuart J.;
    • Blackbourn, Luke A. K.;
    • Hatam, Sara;
    • Kennon, Brian;
    • McCrimmon, Rory J.;
    • Leese, Graham;
    • Philip, Sam;
    • Sattar, Naveed;
    • McKeigue, Paul M.;
    • Colhoun, Helen M.
    Publication type:
    Article
    11
    12

    Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1320, doi. 10.1007/s00125-021-05413-7
    By:
    • Jeyam, Anita;
    • Gibb, Fraser W.;
    • McKnight, John A.;
    • Kennon, Brian;
    • O'Reilly, Joseph E.;
    • Caparrotta, Thomas M.;
    • Höhn, Andreas;
    • McGurnaghan, Stuart J.;
    • Blackbourn, Luke A. K.;
    • Hatam, Sara;
    • McCrimmon, Rory J.;
    • Leese, Graham;
    • Lindsay, Robert S.;
    • Petrie, John;
    • Chalmers, John;
    • Philip, Sam;
    • Wild, Sarah H.;
    • Sattar, Naveed;
    • McKeigue, Paul M.;
    • Colhoun, Helen M.
    Publication type:
    Article
    13

    The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.

    Published in:
    Diabetologia, 2021, v. 64, n. 6, p. 1309, doi. 10.1007/s00125-021-05394-7
    By:
    • Höhn, Andreas;
    • Jeyam, Anita;
    • Caparrotta, Thomas M.;
    • McGurnaghan, Stuart J.;
    • O'Reilly, Joseph E.;
    • Blackbourn, Luke A. K.;
    • McCrimmon, Rory J.;
    • Leese, Graham P.;
    • McKnight, John A.;
    • Kennon, Brian;
    • Lindsay, Robert S.;
    • Sattar, Naveed;
    • Wild, Sarah H.;
    • McKeigue, Paul M.;
    • Colhoun, Helen M.
    Publication type:
    Article
    14
    15
    16
    17

    Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017.

    Published in:
    Diabetologia, 2020, v. 63, n. 8, p. 1626, doi. 10.1007/s00125-020-05173-w
    By:
    • O'Reilly, Joseph E.;
    • Blackbourn, Luke A. K.;
    • Caparrotta, Thomas M.;
    • Jeyam, Anita;
    • Kennon, Brian;
    • Leese, Graham P.;
    • Lindsay, Robert S.;
    • McCrimmon, Rory J.;
    • McGurnaghan, Stuart J.;
    • McKeigue, Paul M.;
    • McKnight, John A.;
    • Petrie, John R.;
    • Philip, Sam;
    • Sattar, Naveed;
    • Wild, Sarah H.;
    • Colhoun, Helen M.
    Publication type:
    Article
    18
    19
    20

    Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016.

    Published in:
    Diabetologia, 2019, v. 62, n. 8, p. 1375, doi. 10.1007/s00125-019-4900-7
    By:
    • Mair, Colette;
    • Wulaningsih, Wahyu;
    • Jeyam, Anita;
    • McGurnaghan, Stuart;
    • Blackbourn, Luke;
    • Kennon, Brian;
    • Leese, Graham;
    • Lindsay, Robert;
    • McCrimmon, Rory J.;
    • McKnight, John;
    • Petrie, John R.;
    • Sattar, Naveed;
    • Wild, Sarah H.;
    • Conway, Nicholas;
    • Craigie, Ian;
    • Robertson, Kenneth;
    • Bath, Louise;
    • McKeigue, Paul M.;
    • Colhoun, Helen M.
    Publication type:
    Article
    21

    The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study.

    Published in:
    Diabetologia, 2019, v. 62, n. 4, p. 621, doi. 10.1007/s00125-018-4806-9
    By:
    • McGurnaghan, Stuart J.;
    • Brierley, Liam;
    • Caparrotta, Thomas M.;
    • McKeigue, Paul M.;
    • Blackbourn, Luke A. K.;
    • Wild, Sarah H.;
    • Leese, Graham P.;
    • McCrimmon, Rory J.;
    • McKnight, John A.;
    • Pearson, Ewan R.;
    • Petrie, John R.;
    • Sattar, Naveed;
    • Colhoun, Helen M.;
    • on behalf of the Scottish Diabetes Research Network Epidemiology Group
    Publication type:
    Article
    22
    23
    24
    25

    Association between recent exposure to continuous glucose monitoring‐recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3213, doi. 10.1111/dom.15649
    By:
    • Svensson, Cecilie H.;
    • Fabricius, Therese W.;
    • Verhulst, Clementine E. M.;
    • Kristensen, Peter L.;
    • Tack, Cees J.;
    • Heller, Simon R.;
    • Amiel, Stephanie A.;
    • McCrimmon, Rory J.;
    • Evans, Mark;
    • Holst, Jens J.;
    • de Galan, Bastiaan E.;
    • Pedersen‐Bjergaard, Ulrik
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1360, doi. 10.1111/dom.14712
    By:
    • Parker, Victoria E. R.;
    • Hoang, Thuong;
    • Schlichthaar, Heike;
    • Gibb, Fraser W.;
    • Wenzel, Barbara;
    • Posch, Maximillian G.;
    • Rose, Ludger;
    • Chang, Yi‐Ting;
    • Petrone, Marcella;
    • Hansen, Lars;
    • Ambery, Philip;
    • Jermutus, Lutz;
    • Heerspink, Hiddo J. L.;
    • McCrimmon, Rory J.
    Publication type:
    Article
    32

    Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1221, doi. 10.1111/dom.14354
    By:
    • McCrimmon, Rory J.;
    • Al Sifri, Saud;
    • Emral, Rifat;
    • Mohan, Viswanathan;
    • Sauque‐Reyna, Leobardo;
    • Trescolí, Carlos;
    • Lalic, Nebojsa;
    • Alvarez, Agustina;
    • Demil, Nacima;
    • Coudert, Mathieu;
    • Shaunik, Alka;
    • Bonnemaire, Mireille;
    • Rosenstock, Julio
    Publication type:
    Article
    33

    Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 8, p. 1967, doi. 10.1111/dom.13791
    By:
    • Davies, Melanie J.;
    • Russell‐Jones, David;
    • Barber, Thomas M.;
    • Lavalle‐González, Fernando J.;
    • Galstyan, Gagik R.;
    • Zhu, Dalong;
    • Baxter, Mike;
    • Dessapt‐Baradez, Cecile;
    • McCrimmon, Rory J.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.

    Published in:
    Diabetologia, 2024, v. 67, n. 10, p. 2160, doi. 10.1007/s00125-024-06233-1
    By:
    • Søholm, Uffe;
    • Broadley, Melanie;
    • Zaremba, Natalie;
    • Divilly, Patrick;
    • Baumann, Petra Martina;
    • Mahmoudi, Zeinab;
    • Martine-Edith, Gilberte;
    • Mader, Julia K.;
    • Cigler, Monika;
    • Brøsen, Julie Maria Bøggild;
    • Vaag, Allan;
    • Heller, Simon;
    • Pedersen-Bjergaard, Ulrik;
    • McCrimmon, Rory J.;
    • Renard, Eric;
    • Evans, Mark;
    • de Galan, Bastiaan;
    • Abbink, Evertine;
    • Amiel, Stephanie A.;
    • Hendrieckx, Christel
    Publication type:
    Article
    40

    Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.

    Published in:
    Diabetologia, 2024, v. 67, n. 10, p. 2210, doi. 10.1007/s00125-024-06225-1
    By:
    • Mellor, Joseph;
    • Kuznetsov, Dmitry;
    • Heller, Simon;
    • Gall, Mari-Anne;
    • Rosilio, Myriam;
    • Amiel, Stephanie A.;
    • Ibberson, Mark;
    • McGurnaghan, Stuart;
    • Blackbourn, Luke;
    • Berthon, William;
    • Salem, Adel;
    • Qu, Yongming;
    • McCrimmon, Rory J.;
    • de Galan, Bastiaan E.;
    • Pedersen-Bjergaard, Ulrik;
    • Leaviss, Joanna;
    • McKeigue, Paul M.;
    • Colhoun, Helen M.
    Publication type:
    Article
    41
    42
    43
    44
    45

    Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.

    Published in:
    Diabetologia, 2024, v. 67, n. 8, p. 1588, doi. 10.1007/s00125-024-06177-6
    By:
    • Mellor, Joseph;
    • Kuznetsov, Dmitry;
    • Heller, Simon;
    • Gall, Mari-Anne;
    • Rosilio, Myriam;
    • Amiel, Stephanie A.;
    • Ibberson, Mark;
    • McGurnaghan, Stuart;
    • Blackbourn, Luke;
    • Berthon, William;
    • Salem, Adel;
    • Qu, Yongming;
    • McCrimmon, Rory J.;
    • de Galan, Bastiaan E.;
    • Pedersen-Bjergaard, Ulrik;
    • Leaviss, Joanna;
    • McKeigue, Paul M.;
    • Colhoun, Helen M.
    Publication type:
    Article
    46
    47
    48
    49
    50